News
Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...
GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...
Researchers analyzed 11 different studies to understand weight outcomes after stopping anti-obesity medications called ...
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.
The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...
West Pharmaceutical stock was climbing 19% on Thursday, putting it on track for the strongest single-day percentage increase ...
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...
More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...
Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results